4 results  1 of 1 

1 Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
Marta Braschi-Amirfarzan, Sree Harsha Tirumani, Frank Stephen Hodi, Mizuki Nishino
Korean J Radiol.2017;18(1):42-53.   Published online 2017 January 5     DOI: http://dx.doi.org/10.3348/kjr.2017.18.1.42
      
2 Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
Yoo Na Kim, Ho Yun Lee, Kyung Soo Lee, Joon Beom Seo, Myung Jin Chung, Myung-Ju Ahn, Keunchil Park, Tae Sung Kim, Chin A Yi
Korean J Radiol.2012;13(6):702-710.   Published online 2012 October 12     DOI: http://dx.doi.org/10.3348/kjr.2012.13.6.702
      
3 Molecularly Targeted Therapy Using Bevacizumab for Non-Small Cell Lung Cancer: a Pilot Study for the New CT Response Criteria
Ho Yun Lee, Kyung Soo Lee, Hye Sun Hwang, Ju Won Lee, Myung-Ju Ahn, Keunchil Park, Tae Sung Kim, Chin A Yi, Myung Jin Chung
Korean J Radiol.2010;11(6):618-626.   Published online 2010 October 29     DOI: http://dx.doi.org/10.3348/kjr.2010.11.6.618
      
4 The Clinical Guidelines for Myelodysplastic Syndrome
June-Won Cheong, Hoon Kook, Soo-Mee Bang, Je Hwan Lee, Yong-Don Joo, Inho Kim, Hyeoung Joon Kim, Chan-Jeoung Park, Hyeon-Jin Park, Jin Seok Ahn, Sung-Soo Yoon, Jong-Ho Won, Mark Hong Lee, Chul Won Jung, Deog-Yeon Jo, Bin Cho, Kyoung Ja Han, Yoo Hong Min, Sun Hee Kim
Korean J Hematol.2007;42(2):71-90.   Published online 2007 June 19     DOI: http://dx.doi.org/10.5045/kjh.2007.42.2.71
   

 1 of 1